Skip to Content

Of Mice and Men

About one million Americans carry the hepatitis B virus (HBV) which can lead to liver cancer. But the search for treatments has been stymied by the lack of a suitable animal for testing new drugs. Rodents don’t get HBV, and chimpanzees, which do, are expensive.

XTL Biopharmacueticals in Rehovot, Israel, has come up with a solution by creating a mouse with a bit of human liver inside it. XTL’s recipe: destroy the immune system of a normal mouse with gamma rays. Next, transplant a peppercorn-sized fragment of HBV-infected human liver, along with bone marrow from an immune-deficient mouse. XTL calls the resulting creature a “trimera” because it has components of three different animals. Since the mouse’s weak immune system doesn’t reject the human cells, there is time to test the effects of anti-viral drugs. XTL hopes to develop trimera models for cancer.

Keep Reading

Most Popular

A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?

Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.

A startup says it’s begun releasing particles into the atmosphere, in an effort to tweak the climate

Make Sunsets is already attempting to earn revenue for geoengineering, a move likely to provoke widespread criticism.

10 Breakthrough Technologies 2023

Every year, we pick the 10 technologies that matter the most right now. We look for advances that will have a big impact on our lives and break down why they matter.

These exclusive satellite images show that Saudi Arabia’s sci-fi megacity is well underway

Weirdly, any recent work on The Line doesn’t show up on Google Maps. But we got the images anyway.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.